Literature DB >> 21078910

Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway.

Mario Galgani1, Claudio Procaccini, Veronica De Rosa, Fortunata Carbone, Paolo Chieffi, Antonio La Cava, Giuseppe Matarese.   

Abstract

Chronic inflammation can associate with autoreactive immune responses, including CD4(+) T cell responses to self-Ags. In this paper, we show that the adipocyte-derived proinflammatory hormone leptin can affect the survival and proliferation of autoreactive CD4(+) T cells in experimental autoimmune encephalomyelitis, an animal model of human multiple sclerosis. We found that myelin olygodendrocyte glycoprotein peptide 35-55 (MOG(35-55))-specific CD4(+) T cells from C57BL/6J wild-type mice could not transfer experimental autoimmune encephalomyelitis into leptin-deficient ob/ob mice. Such a finding was associated with a reduced proliferation of the transferred MOG(35-55)-reactive CD4(+) T cells, which had a reduced degradation of the cyclin-dependent kinase inhibitor p27(kip1) and ERK1/2 phosphorylation. The transferred cells displayed reduced Th1/Th17 responses and reduced delayed-type hypersensitivity. Moreover, MOG(35-55)-reactive CD4(+) T cells in ob/ob mice underwent apoptosis that associated with a downmodulation of Bcl-2. Similar results were observed in transgenic AND-TCR- mice carrying a TCR specific for the pigeon cytochrome c 88-104 peptide. These molecular events reveal a reduced activity of the nutrient/energy-sensing AKT/mammalian target of rapamycin pathway, which can be restored in vivo by exogenous leptin replacement. These results may help to explain a link between chronic inflammation and autoimmune T cell reactivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078910     DOI: 10.4049/jimmunol.1001674

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  Role of Metabolism in the Immunobiology of Regulatory T Cells.

Authors:  Mario Galgani; Veronica De Rosa; Antonio La Cava; Giuseppe Matarese
Journal:  J Immunol       Date:  2016-10-01       Impact factor: 5.422

Review 2.  mTOR signaling, Tregs and immune modulation.

Authors:  Nicole M Chapman; Hongbo Chi
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

Review 3.  Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  J Immunol       Date:  2012-05-15       Impact factor: 5.422

Review 4.  Regulation and function of mTOR signalling in T cell fate decisions.

Authors:  Hongbo Chi
Journal:  Nat Rev Immunol       Date:  2012-04-20       Impact factor: 53.106

5.  Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.

Authors:  Giuseppe Matarese; Claudia La Rocca; Hyun-Seuk Moon; Joo Young Huh; Mary T Brinkoetter; Sharon Chou; Francesco Perna; Dario Greco; Holly P Kilim; Chuanyun Gao; Kalliope Arampatzi; Zhaoxi Wang; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 6.  mTOR, metabolism, and the regulation of T-cell differentiation and function.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 7.  Towards a 'systems'-level understanding of the nervous system and its disorders.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Neurosci       Date:  2013-08-27       Impact factor: 13.837

Review 8.  mTOR and lymphocyte metabolism.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Curr Opin Immunol       Date:  2013-05-28       Impact factor: 7.486

9.  Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity.

Authors:  Valerie A Gerriets; Keiko Danzaki; Rigel J Kishton; William Eisner; Amanda G Nichols; Donte C Saucillo; Mari L Shinohara; Nancie J MacIver
Journal:  Eur J Immunol       Date:  2016-06-13       Impact factor: 5.532

Review 10.  Regulatory T cells, mTOR kinase, and metabolic activity.

Authors:  Claudio Procaccini; Giuseppe Matarese
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.